JNJ Stock Forecast, Price Targets, Chart, Dividends & Analysis

Dividend Per Share TTM ($)	3.67
Forward Annual Dividend Yield	3.38%
Ex Dividend Date (MM/DD/YYYY)	11/26/2024
Dividend Pay Date (MM/DD/YYYY)	9/10/2024
Dividend Yield (TTM)	2.55%
Forward Annual Dividend Rate ($)	4.96
Dividend Payout Ratio	-33.48
Dividend Per Share 5 Year CAGR	0.00%

Analyst Estimates

EPS Estimate Current Year ($)	9.94
EPS Estimate Next Year ($)	10.55
EPS Estimate Next Quarter ($)	2.63
EPS Estimate Current Quarter ($)	2.00
Current Target Price ($)	175.83
Next 5 Year Growth Rate (%)	5.8
1 week Ago Target Price ($)	175.95
2 week Ago Target Price ($)	175.95
3 week Ago Target Price ($)	175.95

Financial Health

Cash Flow Per Share TTM ($)	10.44
Current Ratio	1.00
Quick Ratio	0.70
Debt to Equity Ratio (Last Quarter)	0.43
Long term debt per share (Last Quarter)
F Score	7.0

Technicals

RSI (14 Day)	28.30
14 Day SMA ($)	148.10
14 Day EMA ($)	147.74
Money Flow Index	85.93
Average True Range	2.32
50 Day SMA ($)	155.59
200 Day SMA ($)	154.99
ADX	37.54
MACD	-0.97

Growth

Free Cash Flow QoQ Growth	0.00%
Free Cash Flow YoY Growth	0.00%
Revenue YoY Growth	0.00%
EPS QoQ Growth	0.00%
Revenue QoQ Growth	0.00%
EPS YoY Growth	0.00%

Profitability

Return on Assets TTM (%)	8.53
Profit Margin TTM (%)	21.6
Return on Equity TTM (%)	20.77
Return on Capital TTM (%)	14.7
Interest Coverage Ratio	66.90
Gross Margin TTM (%)	70.3

Peers

Stock	Dividend	Market Cap (B)	PE	Price ($)
ABT	0.0195	196 B	34.23	112.42
GILD	0.0335	116 B	1022.78	91.09
GSK
LLY	0.0077	739 B	85.26	757.54
MDT	0.0339	104 B	24.8	79.99
MRK	0.0324	253 B	20.98	99.52
NVS
PFE	0.0657	150 B	33.69	25.77
SNY
SYK	0.009	141 B	39.95	357.14

Pull option chain for the stock and check the payoff of your option strategies here

Financials

Income Statement

Balance Sheet

Cash Flow

JNJ Income Statement

Annual

	Dec-14	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23
AcquisitionExpense									300 M
Amortization of intangibles	-741 M		-75 M	-3,000 M	-4,400 M	47,643 M	53,402 M	-9 M
Basic EPS from continuing operations	5.8		6.04			5.72	5.59	7.93	6.83	5.26
Basic EPS total	5.8	5.56	6.04	0.48	5.7	5.72	5.59	7.93	6.83	13.88
Basic weighted shares outstanding	2,815 M	2,772 M	2,737 M	2,692 M	2,682 M	2,645 M	2,633 M	2,632 M	2,625 M	2,534 M
BasicDiscontinuousOperations										8.62
Cost of sales	22,746 M	21,536 M	21,685 M	25,439 M	27,091 M	27,556 M	28,427 M	23,402 M	24,596 M	26,553 M
Depreciation	3,895 M		3,754 M	-5,642 M	-6,929 M	7,009 M	7,231 M	7,390 M	6,970 M	7,486 M
DepreciationAndAmortization	3,895 M		3,754 M	-5,642 M	-6,929 M	7,009 M	7,231 M	7,390 M	6,970 M	7,486 M
Diluted EPS total	5.7	5.48	5.93	0.47	5.61	5.63	5.51	7.81	6.73	13.72
Diluted normalized net income/share	5.7		5.93			5.63	5.51	7.81	6.73	5.2
Diluted weighted shares outstanding	2,864 M	2,813 M	2,789 M	2,745 M	2,729 M	2,684 M	2,671 M	2,674 M	2,664 M	2,560 M
DilutedDiscontinuousOperations										8.52
Dividends paid per share	2.76	2.95	3.15	3.32	3.54	3.75	3.98	4.19	4.45	4.7
GainOnSaleOfPPE	2,400 M		600 M	1,300 M	1,200 M	2,154 M
GainOnSaleOfSecurity				-5 M						-400 M
GainsLossOnDisposalOfDiscontinuedOperations									8,459 M	20,984 M
GeneralAndAdministrativeExpense	21,954 M		19,945 M	-372 M	-332 M	22,178 M	22,084 M	24,659 M	20,246 M	21,512 M
Gross operating profit	51,585 M	48,538 M	50,205 M	51,011 M	54,490 M	54,503 M	54,157 M	55,338 M	55,394 M	58,606 M
ImpairmentOfCapitalAssets	410 M		283 M	-1,307 M	-1,258 M	1,096 M		989 M	1,216 M
Income before tax	20,563 M	19,196 M	19,803 M	17,673 M	17,999 M	17,328 M	16,497 M	22,776 M	19,359 M	15,062 M
Income restructuring and M&A		509 M	491 M	309 M	251 M	266 M	247 M	252 M	275 M	489 M
Income taxes	4,240 M	3,787 M	3,263 M	16,373 M	2,702 M	2,209 M	1,783 M	1,377 M	2,989 M	1,736 M
Interest income	67 M	128 M	368 M	385 M	611 M	357 M	111 M	53 M	490 M	1,261 M
InterestExpenseNonOperating	533 M	552 M	726 M	934 M	1,005 M	318 M	201 M	183 M	276 M	772 M
InterestIncomeOperating				1000000.0	1000000.0
MinorityInterests	69,752 M		70,418 M			59,471 M	63,278 M		-1,571 M	-21,827 M
MiscOtherSpecialCharges	70 M	2,064 M	-484 M	42 M	-1,405 M	-2,525 M	-2,899 M	-489 M	-810 M	-6,634 M
Net income from total operations	16,323 M	15,409 M	16,540 M	1,300 M	15,297 M	15,119 M	14,714 M	20,878 M	17,941 M	35,153 M
NetIncomeCommonStockholders	16,323 M	15,409 M	16,540 M	1,300 M	15,297 M	15,119 M	14,714 M	20,878 M	17,941 M	35,153 M
NetIncomeContinuousOperations	16,323 M	15,409 M	16,540 M	1,300 M	15,297 M	15,119 M	14,714 M	20,878 M	16,370 M	13,326 M
NetIncomeDiscontinuousOperations									-4,519 M	-3,085 M
NetNonOperatingInterestIncomeExpense	-466 M	-424 M	-358 M	-549 M	-394 M	39 M	-90 M	-130 M	214 M	489 M
NonRecurringOperationExpense	1,253 M			-645 M	-1,288 M					-100 M
Normalized income	12,629 M		13,046 M
Operating income	20,959 M	18,065 M	21,136 M	18,489 M	20,049 M	20,080 M	19,733 M	23,647 M	21,013 M	22,009 M
Operating income before depreciation (EBITDA)	24,991 M	23,494 M	24,283 M	24,249 M	25,933 M	24,655 M	23,929 M	26,751 M	26,605 M	23,320 M
OperatingExpense	30,626 M	30,473 M	29,069 M	32,522 M	34,441 M	34,423 M	34,424 M	40,273 M	33,181 M	35,197 M
Other income net	-70 M	-2,064 M	484 M	-42 M	1,405 M	2,525 M	2,899 M	489 M	-3,058 M	-8,802 M
OtherGainLossFromDispositionOfDiscontinuedOperations									14,953 M	22,134 M
OtherGandA	21,954 M		19,945 M	-372 M	-332 M	22,178 M	22,084 M	24,659 M	20,246 M	21,512 M
OtherOperatingExpenses	-281 M		-348 M	-332 M	-332 M	-249 M	-265 M	-242 M	-523 M	-239 M
PromotionAndAdvertising	2,600 M		2,400 M	-2,500 M	-2,600 M	2,200 M	2,100 M	2,700 M	700 M	500 M
RentAndLandingFees	341 M		330 M	-372 M	-332 M
Research & development expense	8,672 M	9,270 M	9,124 M	11,002 M	11,901 M	12,245 M	12,340 M	15,614 M	14,135 M	15,085 M
ResearchExpense	8,672 M	9,270 M	9,124 M	11,002 M	11,901 M	12,245 M	12,340 M	15,614 M	14,135 M	15,085 M
RestructringAndMnAIncome		509 M	491 M	309 M	251 M	266 M	247 M	252 M	275 M	489 M
Revenue per share	-741 M		-75 M	-3,000 M	-4,400 M	47,643 M	53,402 M	-9 M
SalariesAndWages	-259 M		-256 M	-962 M	-978 M	-227 M	-210 M	-218 M	-177 M	-221 M
Selling Gen & administrative expense	21,954 M	21,203 M	19,945 M	21,520 M	22,540 M	22,178 M	22,084 M	24,659 M	20,246 M	21,512 M
SellingAndMarketingExpense	2,600 M	21,203 M	2,400 M	21,520 M	22,540 M	2,200 M	2,100 M	2,700 M	700 M	500 M
SellingExpense		21,203 M		21,520 M	22,540 M
Special income/charges	-1,663 M	-509 M	-491 M	-309 M	-251 M	-266 M	-247 M	-252 M	-275 M	-489 M
Total Income available for interest expense (EBIT)	21,096 M	19,748 M	20,529 M	18,607 M	19,004 M	17,646 M	16,698 M	19,361 M	19,635 M	15,834 M
Total common shares outstanding	2,780 M	2,759 M	2,713 M	2,683 M	2,663 M	2,635 M	2,629 M	2,629 M	2,604 M	2,409 M
Total net income	16,323 M	15,409 M	16,540 M	1,300 M	15,297 M	15,119 M	14,714 M	20,878 M	17,941 M	35,153 M
Total ordinary shares	2,408 M	2,408 M	2,408 M	2,408 M	2,408 M	2,408 M	2,408 M	2,408 M	2,408 M	2,408 M
Total revenues	74,331 M	70,074 M	71,890 M	76,450 M	81,581 M	82,059 M	82,584 M	93,775 M	79,990 M	85,159 M
TotalExpenses	53,372 M	52,009 M	50,754 M	57,961 M	61,532 M	61,979 M	62,851 M	70,128 M	57,777 M	61,750 M
TotalRevenue	74,331 M	70,074 M	71,890 M	76,450 M	81,581 M	82,059 M	82,584 M	93,775 M	79,990 M	85,159 M
WriteDown				-177 M	-1,348 M

<< PREVIOUS STOCK

NEXT STOCK>>

Call: 1-877-778-8358

Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.

Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University

JNJ Stock Forecast, Price Targets, Chart, Dividends & Analysis

Johnson & Johnson

Sector: Healthcare

Industry: Drug Manufacturers - Major

Stock Rankings

Valuation

Price per Sales TTM ($)

Price per Book TTM ($)

PE Ratio (TTM)

Book Value per Share ($)

5 Year PE Range

Returns

7 Day Return

1 Month Return

3 Month Return

1 Year Return

3 Year Return

5 Year Return

YTD Return

Risk

Custom Beta One Year

Custom Beta Three Years

Beneish M Score

Altman Z Score

Ranks

MarketXLS Value Score

MarketXLS Quality Score

MarketXLS Technical Score

MarketXLS Rank

Dividends

Dividend Per Share TTM ($)

Forward Annual Dividend Yield

Ex Dividend Date (MM/DD/YYYY)

Dividend Pay Date (MM/DD/YYYY)

Dividend Yield (TTM)

Forward Annual Dividend Rate ($)

Dividend Payout Ratio

Dividend Per Share 5 Year CAGR

Analyst Estimates

EPS Estimate Current Year ($)

EPS Estimate Next Year ($)

EPS Estimate Next Quarter ($)

EPS Estimate Current Quarter ($)

Current Target Price ($)

Next 5 Year Growth Rate (%)

1 week Ago Target Price ($)

2 week Ago Target Price ($)

3 week Ago Target Price ($)

Financial Health

Cash Flow Per Share TTM ($)

Current Ratio

Quick Ratio

Debt to Equity Ratio (Last Quarter)

Long term debt per share (Last Quarter)

F Score

Technicals

RSI (14 Day)

14 Day SMA ($)

14 Day EMA ($)

Money Flow Index

Average True Range

50 Day SMA ($)

200 Day SMA ($)

ADX

MACD

Growth

Free Cash Flow QoQ Growth

Free Cash Flow YoY Growth

Revenue YoY Growth

EPS QoQ Growth

Revenue QoQ Growth

EPS YoY Growth

Profitability

Return on Assets TTM (%)

Profit Margin TTM (%)

Return on Equity TTM (%)

Return on Capital TTM (%)

Interest Coverage Ratio

Gross Margin TTM (%)

Peers